IT8567478A0 - Composizione farmaceutica a base di difosfonati per il trattamento dell artrosi - Google Patents

Composizione farmaceutica a base di difosfonati per il trattamento dell artrosi

Info

Publication number
IT8567478A0
IT8567478A0 IT8567478A IT6747885A IT8567478A0 IT 8567478 A0 IT8567478 A0 IT 8567478A0 IT 8567478 A IT8567478 A IT 8567478A IT 6747885 A IT6747885 A IT 6747885A IT 8567478 A0 IT8567478 A0 IT 8567478A0
Authority
IT
Italy
Prior art keywords
diphosphonates
arthrosis
treatment
pharmaceutical composition
composition based
Prior art date
Application number
IT8567478A
Other languages
English (en)
Other versions
IT1187828B (it
Inventor
Sergio Rosini
Luciano Fontanelli
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Priority to IT67478/85A priority Critical patent/IT1187828B/it
Publication of IT8567478A0 publication Critical patent/IT8567478A0/it
Priority to AT86200822T priority patent/ATE125706T1/de
Priority to DE3650358T priority patent/DE3650358T2/de
Priority to EP86200822A priority patent/EP0203649B1/en
Priority to US07/127,191 priority patent/US4814326A/en
Application granted granted Critical
Publication of IT1187828B publication Critical patent/IT1187828B/it
Priority to HK98105381.9A priority patent/HK1006154B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT67478/85A 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi IT1187828B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
AT86200822T ATE125706T1 (de) 1985-05-24 1986-05-13 Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
DE3650358T DE3650358T2 (de) 1985-05-24 1986-05-13 Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
EP86200822A EP0203649B1 (en) 1985-05-24 1986-05-13 Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
US07/127,191 US4814326A (en) 1985-05-24 1987-12-01 Pharmaceutical compositions based on diphosphonates for the treatment of arthrosis and osteoarthritis
HK98105381.9A HK1006154B (en) 1985-05-24 1998-06-16 Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi

Publications (2)

Publication Number Publication Date
IT8567478A0 true IT8567478A0 (it) 1985-05-24
IT1187828B IT1187828B (it) 1987-12-23

Family

ID=11302741

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi

Country Status (5)

Country Link
US (1) US4814326A (it)
EP (1) EP0203649B1 (it)
AT (1) ATE125706T1 (it)
DE (1) DE3650358T2 (it)
IT (1) IT1187828B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
FI89365C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
EP0522576A3 (en) * 1991-07-12 1993-07-14 Hoechst Aktiengesellschaft Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US6410782B1 (en) * 1997-07-09 2002-06-25 Geange Ltd. Diphosphonic acid salts for the treatment of osteoporosis
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
PT1178810E (pt) * 1999-05-21 2005-08-31 Novartis Ag Utilizacao de acidos bisfosfonicos para o tratamento de angiogenese
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
EP1136069A1 (en) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration
CA2438848C (en) * 2001-03-01 2011-05-03 Emisphere Technologies, Inc. Compositions for delivering bisphosphonates
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
TWI315982B (en) 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
ITTO20020406A1 (it) * 2002-05-13 2003-11-13 Chiesi Farma Spa Formulazioni di bisfosfonati ad uso iniettabile.
AU2003227524A1 (en) * 2002-05-31 2003-12-19 Kobenhavns Universitet Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
ITMI20052515A1 (it) 2005-12-29 2007-06-30 Abiogen Pharma Spa Formulazione farmaceutica per il trattamento della osteoartrite
US20090197837A1 (en) * 2008-02-05 2009-08-06 Desai Vivek S Alendronate formulations, method of making and method of use thereof
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
EP4360627A1 (fr) * 2022-10-26 2024-05-01 Institut National de la Santé et de la Recherche Médicale (INSERM) Traitement de l'arthrose par des inhibiteurs de comt

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA777769A (en) * 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
US3471406A (en) * 1965-09-07 1969-10-07 Plains Chem Dev Co Detergent compositions containing methane tri and tetra phosphonic acid compounds
CA790610A (en) * 1965-12-28 1968-07-23 T. Quimby Oscar Diphosphonate compounds and detergent compositions
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
GB1421064A (en) * 1973-03-09 1976-01-14 Procter & Gamble Oral compositions for calculus retardation
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
US4330530A (en) * 1980-12-22 1982-05-18 The Procter & Gamble Company Anti-arthritic compositions and method using gold salts and organophosphonates
IT1194748B (it) * 1981-02-12 1988-09-28 Gentili Ist Spa Composizioni farmaceutiche per il trattamento di osteopatie
EP0088462A3 (en) * 1982-03-01 1984-06-06 The Procter & Gamble Company Anti-inflammatory and rheumatic composition containing organophosphonate and steroid
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate

Also Published As

Publication number Publication date
EP0203649A2 (en) 1986-12-03
HK1006154A1 (en) 1999-02-12
US4814326A (en) 1989-03-21
DE3650358T2 (de) 1995-12-21
EP0203649B1 (en) 1995-08-02
DE3650358D1 (de) 1995-09-07
IT1187828B (it) 1987-12-23
ATE125706T1 (de) 1995-08-15
EP0203649A3 (en) 1989-12-06

Similar Documents

Publication Publication Date Title
IT8567478A0 (it) Composizione farmaceutica a base di difosfonati per il trattamento dell artrosi
DK546886D0 (da) Farmaceutisk praeparat
NO171977C (no) 3-aryluracilforbindelser
IT1240360B (it) Uso di un derivato dell'1alfa-idrossivitamina d per la preparazione di un medicamento per il trattamento dell' iperparatiroidismo
IT8648098A0 (it) Composizioni farmaceutiche nasali
FR2577138B1 (fr) Immuno-regulateur a base de l-carnosine
FI92053B (fi) Analogiamenetelmä uuden lääkkeen valmistamiseksi
KR880700906A (ko) 치합기구에서의 치형
IT1197033B (it) Analoghi di ammide-tioammide prostaglandina 7 ossabicicloeptano sostituiti
IT1196682B (it) Preparazione farmaceutica a base di n''-ciano-n-4-piridil-n'-1,2,2-trimetilpropilguanidina,particolarmente per il trattamento dell'ipertensione
FR2580495B1 (fr) Preparation dentaire a base d'emulsanne
DK19186D0 (da) Polycycliske salte
IT8619162A0 (it) Composti acilamminoalcanoilici adattivita' farmaceutica.
IT1188163B (it) Trattamento dell'osteoporosi
ATA37885A (de) Kniegelenkschiene
FI864092A7 (fi) Bruksvagn foersedd med frigoerningsanordning
IT1188160B (it) Trattamento dell'osteoporosi
IT1200467B (it) Formulazione farmaceutica
DK639787D0 (da) Laegemiddelform indeholdende urapidil
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK453785D0 (da) Laegemiddel med grf-virkning
DK309788A (da) Baerelag
IT8520273A0 (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
DK306688D0 (da) Baerelag
IT8249284A0 (it) Medicamenti a base della 9,10-diidroergonina per il trattamento dell'arteriosclerosi

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970528